5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.17▲ | 8.15▲ | 8.16▲ | 8.16▲ | 8.10▲ |
MA10 | 8.15▲ | 8.16▲ | 8.18▲ | 8.10▲ | 8.00▲ |
MA20 | 8.14▲ | 8.19▲ | 8.19▲ | 8.11▲ | 8.03▲ |
MA50 | 8.16▲ | 8.19▼ | 8.17▲ | 7.99▲ | 7.63▲ |
MA100 | 8.19▲ | 8.16▲ | 8.09▲ | 8.05▲ | 7.51▲ |
MA200 | 8.19▲ | 8.10▲ | 8.10▲ | 7.96▲ | 10.01▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | -0.003▼ | -0.008▼ | 0.013▲ | -0.024▼ |
RSI | 60.650▲ | 51.558▲ | 51.269▲ | 53.776▲ | 53.574▲ |
STOCH | 85.926▲ | 48.202 | 33.368 | 67.885 | 66.440 |
WILL %R | 0.000▲ | -29.032 | -52.174 | -28.070 | -28.871 |
CCI | 110.526▲ | 16.667 | -44.253 | 56.119 | 50.767 |
MA | $AUPH Price Crossed Above MA(7) | Set Alert |
Sunday, June 15, 2025 05:56 AM
Key Insights Significantly high institutional ownership implies Aurinia Pharmaceuticals' stock price is sensitive ...
|
Friday, June 06, 2025 02:34 AM
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Free Report) TSE: AUP by 21.9% in the 4th quarter, according ...
|
Sunday, May 18, 2025 11:36 PM
As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow (FCF) matches its profit. To get the accrual ratio we first ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 8.09 | 8.205 | 8.075 | 8.18 | 942,470 |
12/06/25 | 8.10 | 8.315 | 8.10 | 8.23 | 856,397 |
11/06/25 | 8.17 | 8.25 | 8.08 | 8.09 | 830,737 |
10/06/25 | 8.15 | 8.265 | 8.11 | 8.14 | 733,394 |
09/06/25 | 8.19 | 8.25 | 8.091 | 8.14 | 1,009,151 |
06/06/25 | 8.15 | 8.34 | 8.13 | 8.19 | 911,772 |
05/06/25 | 7.96 | 8.14 | 7.91 | 8.09 | 1,037,790 |
04/06/25 | 7.96 | 8.06 | 7.935 | 7.99 | 873,252 |
03/06/25 | 7.97 | 8.065 | 7.8395 | 8.00 | 1,108,391 |
02/06/25 | 7.88 | 8.0089 | 7.80 | 7.96 | 1,040,643 |
|
|
||||
|
|
||||
|
|